Perpetual observational studies: new strategies to support efficient implementation of observational studies and randomized trials in infectious diseases
暂无分享,去创建一个
H. Goossens | M. Koopmans | P. Horby | M. Bonten | J. Dunning | S. Harbarth | T. Jaenisch | J. Rodríguez-Baño | E. Tacconelli | J. Bielicki | A. W. van der Velden | Y. Themistocleous | M. D. de Kraker | B. François | Nasreen Hassoun-Kheir | C. H. van Werkhoven | James Lee | Christopher Butler | A. C. Hernandez Padilla | J. V. van Beek | N. Hassoun-Kheir
[1] H. Goossens,et al. The European clinical research response to optimise treatment of patients with COVID-19: lessons learned, future perspective, and recommendations , 2021, The Lancet Infectious Diseases.
[2] Taro Yamamoto,et al. Implications of human activities for (re)emerging infectious diseases, including COVID-19 , 2020, Journal of physiological anthropology.
[3] Herman Goossens,et al. The Randomized Embedded Multifactorial Adaptive Platform for Community-acquired Pneumonia (REMAP CAP) study: rationale and design , 2020 .
[4] H. Goossens,et al. Oseltamivir plus usual care versus usual care for influenza-like illness in primary care: an open-label, pragmatic, randomised controlled trial , 2019, The Lancet.
[5] A. Voss,et al. Mandatory surveillance and outbreaks reporting of the WHO priority pathogens for research & Discovery of new antibiotics in European countries. , 2019, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[6] R. Laxminarayan,et al. Antibiotic development — economic, regulatory and societal challenges , 2019, Nature Reviews Microbiology.
[7] Leonhard Held,et al. Optimizing the Design and Analysis of Clinical Trials for Antibacterials Against Multidrug-resistant Organisms: A White Paper From COMBACTE’s STAT-Net , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[8] J. Nicholl,et al. Benefits and challenges of using the cohort multiple randomised controlled trial design for testing an intervention for depression , 2017, Trials.
[9] J. Woodcock,et al. Master Protocols to Study Multiple Therapies, Multiple Diseases, or Both. , 2017, The New England journal of medicine.
[10] Jagadeeswara Rao Gaddale. Clinical Data Acquisition Standards Harmonization importance and benefits in clinical data management , 2015, Perspectives in clinical research.